Benutzer: Gast  Login
Dokumenttyp:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review; Review
Autor(en):
Lalive, PH; Neuhaus, O; Benkhoucha, M; Bürger, D; Hohlfeld, R; Zamvil, SS; Weber, MS
Titel:
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
Abstract:
Glatiramer acetate is a synthetic, random copolymer widely used as a first-line agent for the treatment of relapsing-remitting multiple sclerosis (MS). While earlier studies primarily attributed its clinical effect to a shift in the cytokine secretion of CD4+ T helper (T(h)) cells, growing evidence in MS and its animal model, experimental autoimmune encephalomyelitis (EAE), suggests that glatiramer acetate treatment is associated with a broader immunomodulatory effect on cells of both the innate...     »
Zeitschriftentitel:
CNS Drugs
Jahr:
2011
Band / Volume:
25
Heft / Issue:
5
Seitenangaben Beitrag:
401-14
Sprache:
eng
Volltext / DOI:
doi:10.2165/11588120-000000000-00000
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/21476611
Print-ISSN:
1172-7047
TUM Einrichtung:
Neurologische Klinik und Poliklinik
 BibTeX